companydata.dkcompanydata.dk

PHARMACEUTICAL ECONSULTING A/S: Financial statements 2016

CVR: 30815378

Source: annual report 2016, Danish Business Authority

01/10/2015 – 30/09/2016

PHARMACEUTICAL ECONSULTING A/S (CVR 30815378) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 2,961,733 and a net result of DKK -301,438 compared with DKK 0 the year before. Equity in the 2016 report amounted to DKK 4,507,588. The solvency ratio was 54.1%.

Gross Profit
DKK 2,961,733
Profit/Loss
DKK -301,438
Equity
DKK 4,507,588
Total Assets
DKK 8,332,350

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016-3 mio.-301 t.4.5 mio.-
2015--00-
2014--00-
2013--00-
2012--1.8 mio.397 t.-1.3 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like PHARMACEUTICAL ECONSULTING A/S

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2016

PHARMACEUTICAL ECONSULTING A/S: The 2015 annual report is outJul 20, 2016

PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2015. The net result was DKK 0.

Hanne Laurberg Olesen joins the board of PHARMACEUTICAL ECONSULTING A/SJun 14, 2016

As of June 14, 2016, Hanne Laurberg Olesen has joined the board of directors of PHARMACEUTICAL ECONSULTING A/S.

Steen Otto Rugaard joins the board of PHARMACEUTICAL ECONSULTING A/SJun 14, 2016

As of June 14, 2016, Steen Otto Rugaard has joined the board of directors of PHARMACEUTICAL ECONSULTING A/S.

Pernille Laurberg Rugaard joins the board of PHARMACEUTICAL ECONSULTING A/SJun 14, 2016

As of June 14, 2016, Pernille Laurberg Rugaard has joined the board of directors of PHARMACEUTICAL ECONSULTING A/S.

Steen Otto Rugaard joins PHARMACEUTICAL ECONSULTING A/S as adm. dir.Jun 14, 2016

As of June 14, 2016, Steen Otto Rugaard is registered as adm. dir. of PHARMACEUTICAL ECONSULTING A/S.

Hanne Laurberg Olesen leaves the board of PHARMACEUTICAL ECONSULTING A/SApr 6, 2016

As of April 6, 2016, Hanne Laurberg Olesen has left the board of directors of PHARMACEUTICAL ECONSULTING A/S.

Steen Otto Rugaard leaves the board of PHARMACEUTICAL ECONSULTING A/SApr 6, 2016

As of April 6, 2016, Steen Otto Rugaard has left the board of directors of PHARMACEUTICAL ECONSULTING A/S.

Pernille Laurberg Rugaard leaves the board of PHARMACEUTICAL ECONSULTING A/SApr 6, 2016

As of April 6, 2016, Pernille Laurberg Rugaard has left the board of directors of PHARMACEUTICAL ECONSULTING A/S.

Steen Otto Rugaard steps down as director of PHARMACEUTICAL ECONSULTING A/SApr 6, 2016

As of April 6, 2016, Steen Otto Rugaard has stepped down as director of PHARMACEUTICAL ECONSULTING A/S.

About PHARMACEUTICAL ECONSULTING A/S

PHARMACEUTICAL ECONSULTING A/S is a Danish company of the type Aktieselskab based in Glostrup, founded in 2007. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Steen Otto Rugaard. The board consists of Pernille Laurberg Rugaard (chair), Hanne Laurberg Olesen and Steen Otto Rugaard. The company is owned by RUGAARD HOLDING ApS. The company has 9 employees (2026). In 2025, the company reported a gross profit of DKK 6,113,709 and a net result of DKK -1,066,960 compared with DKK -643,853 the year before. Equity in the 2025 report amounted to DKK 5,152,605.

Source: annual report 2025, Danish Business Authority